Intellia Therapeutics (NTLA)
Healthcare · Biotechnology
2 members of Congress have disclosed 6 trades in Intellia Therapeutics (NTLA) since 2017: 4 buys and 2 sales. The most recent was disclosed on Sep 5, 2023.
- Trades disclosed
- 6
- Members trading
- 2
- Buys / sells
- 4 / 2
- Reported value
- $34K–$160K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at NTLA
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded NTLA
- Sen. Thomas R. Carper (D-DE)3 buys · 1 sale31Sep 5, 2023
- Sen. James M. Inhofe (R-OK)1 buy · 1 sale11Nov 8, 2018
All trades
- Sep 5, 2023$1K–$15K
Sen. Thomas R. Carper (D-DE)
Sold (full) Intellia Therapeutics NTLA
$1K–$15K · Traded Aug 25, 2023 · disclosed Sep 5, 2023 · Spouse
- Jun 30, 2023$1K–$15K
Sen. Thomas R. Carper (D-DE)
Bought Intellia Therapeutics NTLA
$1K–$15K · Traded May 22, 2023 · disclosed Jun 30, 2023 · Spouse
- May 17, 2021$1K–$15K
Sen. Thomas R. Carper (D-DE)
Bought Intellia Therapeutics NTLA
$1K–$15K · Traded Nov 20, 2020 · disclosed May 17, 2021 · Spouse · filed 178 days later
- Dec 2, 2020$1K–$15K
Sen. Thomas R. Carper (D-DE)
Bought Intellia Therapeutics NTLA
$1K–$15K · Traded Nov 20, 2020 · disclosed Dec 2, 2020 · Spouse
- Nov 8, 2018$15K–$50K
Sen. James M. Inhofe (R-OK)
Sold (full) Intellia Therapeutics NTLA
$15K–$50K · Traded Oct 25, 2018 · disclosed Nov 8, 2018
- Nov 8, 2017$15K–$50K
Sen. James M. Inhofe (R-OK)
Bought Intellia Therapeutics NTLA
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.